Ilant Health, an obesity treatment company, has launched with $3m in financing, led by healthcare executive Elina Onitskansky.

The company is also backed by Global Medical Response president and CEO Nick Loporcaro; CareBridge, Russell Street Ventures, and Main Street Health chief financial officer (CFO) Brandon Kerns; and Lyra Health CFO Matt Klitus, among others.

It is partnering with employers and health plans to provide individualised and value-based obesity care.

The start-up offers comprehensive care to individuals with obesity, providing evidence-based treatments including surgery, medication, and behavioural therapy through technology and data-driven practices.

It uses a three-step plan to identify those who would most likely see clinical and financial value from treatment. Then, it matches individuals to the treatment most likely to drive outcomes and value and provides an integrated treatment approach for ongoing access to clinical experts.

Besides, Ilant Health is working to make obesity care more affordable and accessible.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Its team is said to include innovators and executives from across the healthcare industry.

Onitskansky said: “Obesity is incredibly complex – it’s a medical problem, a health equity problem, a bias problem, and a cost problem.

“We’re seeing unprecedented increases in conditions and costs associated with obesity – whether that’s cardiometabolic diseases, musculoskeletal issues, or obesity-related cancers – and surging demand for high-cost obesity treatments.

“We’re seeing increasing discussions of obesity – even as the biases and the stigma associated with obesity remain incredibly high.

“We need to get away from simple answers to the obesity epidemic and recognise that the solution needs to be as nuanced and multifaceted as the problem we’re facing.”